- Home
- ATOM vs FDMT Comparison
ATOM vs FDMT Comparison
Compare ATOM & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- FDMT
- Stock Information
- Founded
- ATOM 2001
- FDMT 2013
- Country
- ATOM United States
- FDMT United States
- Employees
- ATOM N/A
- FDMT N/A
- Industry
- ATOM Semiconductors
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- FDMT Health Care
- Exchange
- ATOM Nasdaq
- FDMT Nasdaq
- Market Cap
- ATOM 248.9M
- FDMT 268.6M
- IPO Year
- ATOM 2016
- FDMT 2020
- Fundamental
- Price
- ATOM $5.43
- FDMT $4.28
- Analyst Decision
- ATOM Strong Buy
- FDMT Buy
- Analyst Count
- ATOM 1
- FDMT 10
- Target Price
- ATOM $7.00
- FDMT $35.00
- AVG Volume (30 Days)
- ATOM 635.1K
- FDMT 725.7K
- Earning Date
- ATOM 04-24-2025
- FDMT 05-08-2025
- Dividend Yield
- ATOM N/A
- FDMT N/A
- EPS Growth
- ATOM N/A
- FDMT N/A
- EPS
- ATOM N/A
- FDMT N/A
- Revenue
- ATOM $135,000.00
- FDMT $37,000.00
- Revenue This Year
- ATOM $580.00
- FDMT $11,029.73
- Revenue Next Year
- ATOM N/A
- FDMT $44.15
- P/E Ratio
- ATOM N/A
- FDMT N/A
- Revenue Growth
- ATOM N/A
- FDMT N/A
- 52 Week Low
- ATOM $2.31
- FDMT $3.73
- 52 Week High
- ATOM $17.55
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- ATOM 41.05
- FDMT 43.33
- Support Level
- ATOM $5.39
- FDMT $3.73
- Resistance Level
- ATOM $6.04
- FDMT $4.40
- Average True Range (ATR)
- ATOM 0.58
- FDMT 0.35
- MACD
- ATOM 0.12
- FDMT 0.02
- Stochastic Oscillator
- ATOM 28.57
- FDMT 48.64
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.